Category: St. Jude Medical
Here's a look at some of the top legal news stories for medical device companies this week.
St. Jude Medical says its Prodigy neurostimulation device won CE Mark approval in the European Union for a chronic pain indication.
St. Jude Medical (NYSE:STJ) said it's putting its Prodigy neurostimulation device on the market in Europe for patients with chronic back pain after winning CE Mark approval.
Volcano appeals a Delaware federal judge's dismissal of its lawsuit against St. Jude Medical over fractional flow reserve patents.
St. Jude Medical says it's launched a post-approval study in Europe for its Nanostim leadless pacemaker and performed the 1st implantations in a U.S. pivotal trial.
St. Jude Medical (NYSE:STJ) said it's enrolled the 1st patients in a post-approval trial of the Nanostim leadless pacemaker it acquired in October 2013.
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
Volcano agrees that St. Jude Medical isn't infringing a pair of its fractional flow reserve patents after a court ruling doesn't go its way, but vows to appeal.
Johnson & Johnson's Biosense Webster subsidiary is the 1st to the U.S. market with a force-sensing ablation catheter for atrial fibrillation, the ThermoCool SmartTouch device.
Johnson & Johnson's (NYSE:JNJ) Biosense Webster subsidiary said it won pre-market approval from the FDA for its ThermoCool SmartTouch force-sensing ablation catheter, making it the 1st such device to hit the U.S. market.